Compare NVCR & NEOG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NVCR | NEOG |
|---|---|---|
| Founded | 2000 | 1981 |
| Country | Switzerland | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.3B |
| IPO Year | 2015 | 1989 |
| Metric | NVCR | NEOG |
|---|---|---|
| Price | $13.55 | $9.87 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 6 | 4 |
| Target Price | ★ $26.42 | $10.67 |
| AVG Volume (30 Days) | 1.1M | ★ 4.2M |
| Earning Date | 02-26-2026 | 01-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $642,269,000.00 | ★ $880,319,000.00 |
| Revenue This Year | $9.68 | N/A |
| Revenue Next Year | $6.03 | $2.00 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 11.17 | N/A |
| 52 Week Low | $10.70 | $3.87 |
| 52 Week High | $27.47 | $12.07 |
| Indicator | NVCR | NEOG |
|---|---|---|
| Relative Strength Index (RSI) | 52.25 | 76.18 |
| Support Level | $12.80 | $8.93 |
| Resistance Level | $14.07 | $9.78 |
| Average True Range (ATR) | 0.66 | 0.54 |
| MACD | -0.11 | 0.12 |
| Stochastic Oscillator | 35.52 | 86.66 |
NovoCure Ltd is an oncology company with a propreitary platform technology in United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.
Neogen Corporation, headquartered in Lansing, Michigan, develops, manufactures, and markets various products for food and animal safety. In food safety, the company performs diagnostics to detect unintended substances in food and animal feed, to prevent contamination and foodborne illnesses such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, and ruminant by-products. In animal safety, the company segment is engaged in the development, manufacture, marketing and distribution of veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostic products, rodent control products, cleaners, disinfectants, insect control products and genomics testing services.